Koskisen Oyj (HEL:KOSKI)

Sage Therapeutics Revenue

Koskisen Oyj had revenue of 86.30M EUR in the quarter ending March 31, 2025, with 35.30% growth. This brings the company's revenue in the last twelve months to 305.02M, up 16.42% year-over-year. In the year 2024, Koskisen Oyj had annual revenue of 282.50M with 4.04% growth.

• Revenue (ttm): 305.02M
• Revenue Growth: +16.42%
• P/S Ratio: 0.69
• Revenue / Employee: 324.14K
• Employees: 943
• Market Cap: 211.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	282.50M	10.96M	4.04%
Dec 31, 2023	271.54M	-46.39M	-14.59%
Dec 31, 2022	317.93M	6.25M	2.01%
Dec 31, 2021	311.68M	91.72M	41.70%
Dec 31, 2020	219.96M	-8.98M	-3.92%